Published in Ann Rheum Dis on April 13, 2005
Does occupational therapy reduce the need for surgery in carpometacarpal osteoarthritis? Protocol for a randomized controlled trial. BMC Musculoskelet Disord (2016) 1.39
Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification. Ann Rheum Dis (2011) 1.07
The effect of sulphurous water in patients with osteoarthritis of hand. Double-blind, randomized, controlled follow-up study. Clin Rheumatol (2012) 1.04
Research in hand osteoarthritis: time for reappraisal and demand for new strategies. An opinion paper. Ann Rheum Dis (2007) 0.99
Correlation of pain relief with physical function in hand osteoarthritis: randomized controlled trial post hoc analysis. Arthritis Res Ther (2010) 0.98
Hand osteoarthritis--a heterogeneous disorder. Nat Rev Rheumatol (2011) 0.97
The International Classification of Functioning as an explanatory model of health after distal radius fracture: a cohort study. Health Qual Life Outcomes (2005) 0.96
Exploring the relationships between International Classification of Functioning, Disability and Health (ICF) constructs of Impairment, Activity Limitation and Participation Restriction in people with osteoarthritis prior to joint replacement. BMC Musculoskelet Disord (2011) 0.89
Multidisciplinary and multifaceted outpatient management of patients with osteoarthritis: protocol for a randomised, controlled trial. BMC Musculoskelet Disord (2010) 0.84
Relevance of race and ethnicity for self-reported functional limitation. J Am Geriatr Soc (2008) 0.83
Outcome measures for hand function naturally reveal three latent domains in older adults: strength, coordinated upper extremity function, and sensorimotor processing. Front Aging Neurosci (2015) 0.82
Reduction in Cylindrical Grasp Strength Is Associated With Early Thumb Carpometacarpal Osteoarthritis. Clin Orthop Relat Res (2016) 0.80
Joint-specific hand symptoms and self-reported and performance-based functional status in African Americans and Caucasians: The Johnston County Osteoarthritis Project. Ann Rheum Dis (2007) 0.78
Hydroxychloroquine effectiveness in reducing symptoms of hand osteoarthritis (HERO): study protocol for a randomized controlled trial. Trials (2013) 0.77
Evaluation of Non Diseased Specified Outcome Measures in Hand Injuries to Assess Activity and Participation Based on ICF Content. J Hand Microsurg (2013) 0.77
Test-retest reliability and convergent validity of a computer based hand function test protocol in people with arthritis. Open Orthop J (2015) 0.75
Efficacy of treatments and pain management for trapeziometacarpal (thumb base) osteoarthritis: protocol for a systematic review. BMJ Open (2015) 0.75
Night-time immobilization of the distal interphalangeal joint reduces pain and extension deformity in hand osteoarthritis. Rheumatology (Oxford) (2014) 0.75
Exercise programme with telephone follow-up for people with hand osteoarthritis - protocol for a randomised controlled trial. BMC Musculoskelet Disord (2014) 0.75
Evaluation of validity and reliability of the Persian version of the functional index of hand osteoarthritis. Rheumatol Int (2017) 0.75
Cross-cultural adaptation, validation, and responsiveness of the Korean version of the AUSCAN Osteoarthritis Index. Rheumatol Int (2011) 0.75
Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis. Arthritis Rheum (1989) 5.47
Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. J Rheumatol (1997) 5.09
The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum (1990) 3.97
The importance of enhancing self-efficacy in rheumatoid arthritis. Arthritis Care Res (1997) 2.31
Joint protection and home hand exercises improve hand function in patients with hand osteoarthritis: a randomized controlled trial. Arthritis Rheum (2002) 1.65
Range of joint motion and disability in patients with osteoarthritis of the knee or hip. Rheumatology (Oxford) (2000) 1.60
Questionnaire to evaluate the effects of assistive devices and altered working methods in women with rheumatoid arthritis. Clin Rheumatol (1998) 1.54
Activity loss and the onset of depressive symptoms: do some activities matter more than others? Arthritis Rheum (2001) 1.53
Dimensionality and clinical importance of pain and disability in hand osteoarthritis: Development of the Australian/Canadian (AUSCAN) Osteoarthritis Hand Index. Osteoarthritis Cartilage (2002) 1.47
Clinimetric properties of the AUSCAN Osteoarthritis Hand Index: an evaluation of reliability, validity and responsiveness. Osteoarthritis Cartilage (2002) 1.33
Retracted Value and application of the ICF in rehabilitation medicine. Disabil Rehabil (2003) 1.33
ICF Core Sets for osteoarthritis. J Rehabil Med (2004) 1.29
Defining osteoarthritis of the hand for epidemiological studies: the Chingford Study. Ann Rheum Dis (1994) 1.29
Perceived self-efficacy and pain control: opioid and nonopioid mechanisms. J Pers Soc Psychol (1987) 1.25
A cross-sectional study of the association between Heberden's nodes, radiographic osteoarthritis of the hands, grip strength, disability and pain. Osteoarthritis Cartilage (2001) 1.25
Measuring grip strength in normal adults: reference ranges and a comparison of electronic and hydraulic instruments. J Hand Surg Am (2004) 1.19
Grip force in patients with rheumatoid arthritis and fibromyalgia and in healthy subjects. A study with the Grippit instrument. Scand J Rheumatol (1993) 1.17
The impact of rheumatoid arthritis and osteoarthritis: the activities of patients with rheumatoid arthritis and osteoarthritis compared to controls. J Rheumatol (1987) 1.17
The increasing need for nonoperative treatment of patients with osteoarthritis. Clin Orthop Relat Res (2001) 1.16
Women, men, and osteoarthritis. Arthritis Care Res (1995) 1.14
A controlled study of hand function in nodal and erosive osteoarthritis. Ann Rheum Dis (1989) 1.09
The use of the Canadian occupational performance measure as an outcome of a pain management program. Can J Occup Ther (2001) 1.03
Splinting in the treatment of arthritis of the first carpometacarpal joint. J Hand Surg Am (1999) 1.01
Self-efficacy and health status in rheumatoid arthritis: a two-year longitudinal observational study. Rheumatology (Oxford) (2001) 0.99
Norwegian version of the Canadian Occupational Performance Measure in patients with hand osteoarthritis: validity, responsiveness, and feasibility. Arthritis Rheum (2004) 0.99
The subjective dimension of functioning and disability: what is it and what is it for? Disabil Rehabil (2003) 0.98
Performance of the Norwegian version of AUSCAN--a disease-specific measure of hand osteoarthritis. Osteoarthritis Cartilage (2005) 0.95
Reduction in the need for operation after conservative treatment of osteoarthritis of the first carpometacarpal joint: a seven year prospective study. Scand J Plast Reconstr Surg Hand Surg (2001) 0.93
Evaluation of assistive devices after a course in joint protection. Int J Technol Assess Health Care (1994) 0.92
Session 2: clinical aspects. Clinical assessment of hand OA. Osteoarthritis Cartilage (2000) 0.90
Living with osteoarthritis: patient expenditures, health status, and social impact. Arthritis Rheum (2001) 0.90
Survey of the use and effect of assistive devices in patients with early rheumatoid arthritis: a two-year followup of women and men. Arthritis Rheum (2004) 0.88
Does satisfaction with abilities mediate the relationship between the impact of rheumatoid arthritis on valued activities and depressive symptoms? Arthritis Rheum (2001) 0.88
A comparative evaluation of a fibromyalgia rehabilitation program. Arthritis Care Res (1999) 0.88
A comparison of the Canadian Occupational Performance Measure and the Health Assessment Questionnaire. Can J Occup Ther (2001) 0.87
Prospective analysis of splinting the first carpometacarpal joint: an objective, subjective, and radiographic assessment. J Hand Ther (2000) 0.86
Rethinking the relationships between disability, rehabilitation, and society. Disabil Rehabil (1997) 0.84
Nonpharmacologic management of osteoarthritis. Curr Opin Rheumatol (2002) 0.84
Hand function in osteoarthritis. Arch Phys Med Rehabil (1982) 0.82
The pattern of joint involvement in hands with arthritis at the base of the thumb. Hand (1979) 0.82
The importance of nonpharmacologic approaches in management of osteoarthritis. Am J Med (1998) 0.80
Osteoarthritis. How to manage pain and improve patient function. Geriatrics (2001) 0.80
Severity of hand osteoarthritis and its association with upper extremity impairment in a population of disabled older women: the Women's Health and Aging Study. Aging (Milano) (1999) 0.78
Relationship of self-efficacy to pain behavior. J Rheumatol (1991) 0.78
Assistive technology device use in patients with rheumatic disease: a literature review. Am J Occup Ther (1992) 0.77
The case for nonpharmacologic therapy of osteoarthritis. Curr Rheumatol Rep (2001) 0.77
The possession of technical aids among persons with a somatic chronic disease. Disabil Rehabil (2003) 0.77
Predictors of hand function in older persons: a two-year longitudinal analysis. J Am Geriatr Soc (1995) 0.77
Joint impairment and hand function in the elderly. J Am Geriatr Soc (1992) 0.77
Concern Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med (2000) 29.03
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 6.36
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis (2009) 5.82
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2011) 4.78
EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 4.59
ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2005) 4.31
Current tobacco smoking, formal education, and the risk of rheumatoid arthritis. J Rheumatol (1999) 2.93
European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis (2011) 2.74
Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum (2000) 2.71
Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison. Lancet (2000) 2.63
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis (2008) 2.55
Heartburn treatment in primary care: randomised, double blind study for 8 weeks. BMJ (1999) 2.44
ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis (2008) 2.37
Intra-atrial ECG is not a reliable method for positioning left internal jugular vein catheters. Br J Anaesth (2003) 2.21
Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum (1995) 2.16
The prevalence and severity of rheumatoid arthritis in Oslo. Results from a county register and a population survey. Scand J Rheumatol (1997) 2.13
Consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann Rheum Dis (2006) 2.07
Aquatic exercise for the treatment of knee and hip osteoarthritis. Cochrane Database Syst Rev (2007) 2.06
European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis (2011) 2.06
The role of somatosensory evoked potentials in detecting cerebral ischaemia during carotid endarterectomy. Eur J Anaesthesiol (2008) 2.05
Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut (1997) 2.04
Toward a data-driven evaluation of the 2010 American College of Rheumatology/European League Against Rheumatism criteria for rheumatoid arthritis: is it sensible to look at levels of rheumatoid factor? Arthritis Rheum (2011) 2.01
Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative. Ann Rheum Dis (2011) 1.97
Translation and performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. I. Data quality, scaling assumptions, reliability, and construct validity. J Clin Epidemiol (1998) 1.93
Severity of obstructive airways disease by age 2 years predicts asthma at 10 years of age. Thorax (2007) 1.89
High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis (2007) 1.87
Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies. Ann Rheum Dis (2008) 1.84
Efficiency and costs of medical exercise therapy, conventional physiotherapy, and self-exercise in patients with chronic low back pain. A pragmatic, randomized, single-blinded, controlled trial with 1-year follow-up. Spine (Phila Pa 1976) (1998) 1.79
Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression. Ann Rheum Dis (2007) 1.78
Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine. Ann Rheum Dis (2001) 1.78
Reduced bone mineral density in male rheumatoid arthritis patients: frequencies and associations with demographic and disease variables in ninety-four patients in the Oslo County Rheumatoid Arthritis Register. Arthritis Rheum (2000) 1.77
Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison. Ann Rheum Dis (2006) 1.77
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Arthritis Rheum (2008) 1.66
Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis. Ann Rheum Dis (2006) 1.64
Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev (2008) 1.61
Cortical hand bone loss after 1 year in early rheumatoid arthritis predicts radiographic hand joint damage at 5-year and 10-year follow-up. Ann Rheum Dis (2008) 1.60
Three month treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled study. Ann Rheum Dis (2004) 1.58
Disease activity and health status in rheumatoid arthritis: a case-control comparison between Norway and Lithuania. Ann Rheum Dis (2003) 1.58
Postpartum onset of rheumatoid arthritis and other chronic arthritides: results from a patient register linked to a medical birth registry. Ann Rheum Dis (2009) 1.56
Lower level of synovial fluid interferon-gamma in HLA-B27-positive than in HLA-B27-negative patients with Chlamydia trachomatis reactive arthritis. Rheumatology (Oxford) (2003) 1.55
EULAR recommendations for calcium pyrophosphate deposition. Part II: management. Ann Rheum Dis (2011) 1.54
Validity of physical activity monitors in adults participating in free-living activities. Br J Sports Med (2008) 1.52
Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors. Ann Rheum Dis (2007) 1.51
A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. Genes Immun (2008) 1.47
Homeopathic treatment of migraine: a double blind, placebo controlled trial of 68 patients [see comment]. Br Homeopath J (2000) 1.45
A method for determining the size of internal pilot studies. Stat Med (1996) 1.40
Can childhood asthma be predicted at birth? Clin Exp Allergy (2010) 1.40
Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol (2002) 1.39
A new, brief questionnaire (PEQ) developed in primary health care for measuring patients' experience of interaction, emotion and consultation outcome. Fam Pract (2001) 1.37
Acute sarcoid arthritis: occurrence, seasonal onset, clinical features and outcome. Br J Rheumatol (1995) 1.37
Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study. Ann Rheum Dis (2009) 1.36
Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology. J Rheumatol (1999) 1.35
Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative. Ann Rheum Dis (2008) 1.32
Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun (2005) 1.32
Patient compliance in a clinical trial with inhaled budesonide in children with mild asthma. Eur Respir J (1999) 1.28
Hand cortical bone mass and its associations with radiographic joint damage and fractures in 50-70 year old female patients with rheumatoid arthritis: cross sectional Oslo-Truro-Amsterdam (OSTRA) collaborative study. Ann Rheum Dis (2004) 1.26
Work disability in rheumatoid arthritis is predicted by physical and psychological health status: a 7-year study from the Oslo RA register. Scand J Rheumatol (2006) 1.26
Performance of health status measures with a pen based personal digital assistant. Ann Rheum Dis (2005) 1.25
A comparison of agreement and sensitivity to change between AIMS2 and a short form of AIMS2 (AIMS2-SF) in more than 1,000 rheumatoid arthritis patients. J Rheumatol (2000) 1.24
Health status of patients with ankylosing spondylitis: a comparison with the general population. Ann Rheum Dis (2004) 1.24
Amplification of plasmid and chromosome Chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthropathies. Arthritis Rheum (1995) 1.21
Adalimumab therapy reduces hand bone loss in early rheumatoid arthritis: explorative analyses from the PREMIER study. Ann Rheum Dis (2008) 1.20
Identification of disease activity and health status cut-off points for the symptom state acceptable to patients with rheumatoid arthritis. Ann Rheum Dis (2007) 1.18
Seven year changes in health status and priorities for improvement of health in patients with rheumatoid arthritis. Ann Rheum Dis (2005) 1.18
Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study. Ann Rheum Dis (2010) 1.17
Natural killer (NK) cell activity of peripheral blood, synovial fluid, and synovial tissue lymphocytes from patients with rheumatoid arthritis and juvenile rheumatoid arthritis. Ann Rheum Dis (1982) 1.16
Asthma drug adherence in a long term clinical trial. Arch Dis Child (2000) 1.16
Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2. Rheumatology (Oxford) (1999) 1.16
Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity. Ann Rheum Dis (2007) 1.15
The incidence and severity of rheumatoid arthritis, results from a county register in Oslo, Norway. J Rheumatol (1998) 1.15
Rheumatoid arthritis is milder in the new millennium: health status in patients with rheumatoid arthritis 1994-2004. Ann Rheum Dis (2008) 1.14
Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists. Rheumatology (Oxford) (2008) 1.13
The course of rheumatoid arthritis and predictors of psychological, physical and radiographic outcome after 5 years of follow-up. Rheumatology (Oxford) (2000) 1.12
Ultrasonography shows increased cross-sectional area of the median nerve in patients with arthritis and carpal tunnel syndrome. Rheumatology (Oxford) (2005) 1.10
Musculoskeletal pain and quality of life in patients with noninflammatory joint pain compared to rheumatoid arthritis: a population survey. J Rheumatol (1997) 1.10
Apathy and depressed mood in acquired brain damage: relationship to lesion localization and psychophysiological reactivity. Psychol Med (1999) 1.09
Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis. Ann Rheum Dis (1999) 1.09
Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents. Ann Rheum Dis (2008) 1.08